OSCR - Latest News

Oscar Health, Inc. (OSCR), operates in Healthcare / Medical - Healthcare Plans, trades on NYSE.

Market capitalization stands near $8.49B. Trailing twelve-month P/E ratio is 17.98. Beta to the broader market is 2.38.

The article list below shows the most recent OSCR headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent OSCR Headlines

Best Growth Stocks to Buy for August 14th

zacks.com - Aug 14, 2026

MTCH, PBI, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 14, 2026.

Is Oscar Health Inc (OSCR) Overvalued After 4.0% Rally? GF Value Says Overvalued

gurufocus.com - Aug 13, 2026

On August 13, 2026, Oscar Health Inc (OSCR) shares rose 4. 0% to a current price of $30.

Best Growth Stocks to Buy for August 12th

zacks.com - Aug 12, 2026

MTCH, PBI, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 12, 2026.

Oscar Health Q2 Earnings Call Highlights

marketbeat.com - Aug 8, 2026

Oscar Health NYSE: OSCR reported record profitability for the first half of 2026 and raised its full-year operating outlook, citing membership growth,

GoodRx and Oscar Health Tout Tech as Consumer Needs Change

pymnts.com - Aug 6, 2026

The latest earnings from Oscar Health and GoodRx show both companies dealing with a changing customer base. The former company reported half-year ear

How News Affects OSCR Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track OSCR's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked OSCR news questions

What is the latest OSCR news headline?
The most recent OSCR headline (Aug 14, 2026) is "Best Growth Stocks to Buy for August 14th". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the OSCR news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What OSCR news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual OSCR options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.